I recall when John Brown visited the Habener lab in the '90's at MGH and told us that GLP-1 was "way down on the list" of incretins!
Summary: Mounjaro adverse effects are coded using WHO ICD-10 with the clinical manifestation code followed by Y42.3 to indicate antidiabetic medication involvement
These medications are not FDA approved and have not been evaluated by the FDA for safety, efficacy, or quality
Current and previous batch information, including lot numbers, manufacturing dates, expiration dates, and testing documentation, can also be found on our Lab Results Page
Who qualifies for GLP-1 weight loss therapy in Orange County, CA
You can also use the TRICARE formulary search tool to view the TRICARE formulary (list of covered drugs)